Large amounts of IL‐6 are secreted from BMSCs to stimulate IL‐6/STAT3 pathway signal transduction and significantly increase the invasion rate of liver cancer cells, which can be reversed by anti‐IL‐6 antibodies. This evidence concerns the gene IL6 and liver cancer.